Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Skin biopsy is crucial for diagnosing unknown baldness causes.

Spironolactone can reduce hair growth in women with hirsutism.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Finasteride works best in 6 months and lasts 6 years.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.